Skip to main content
SpringerLink
Log in

Acetylcholinrezeptor-Antikörper-positive generalisierte Myasthenia gravis

Phase-II-Daten zeigen keine Steroideinsparung durch Rituximab

  • Journal club
  • Published:
InFo Neurologie + Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Chan A et al. J Neurol 2007; 254: 1604-6

  2. Wolfe GI et al. NEngl J Med 2016; 375: 511-22

  3. Feng X et al. Front Neurol 2021; 12: https://doi.org/10.3389/fneur.2021.725700

  4. Li T et al. J Clin Neurosci 2021; 85: 6-12

  5. Nelke C et al. J Neurol Neurosurg Psychiatry 2022; 93: 548-54

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Neurologie, St. Josef-Hospital, Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Germany

    Simon Faissner

  2. St. Josef-Hospital, Neurologische Klinik der Ruhr-Universität Bochum, Gudrunstr. 56, 44791, Bochum, Germany

    Ralf Gold

Authors
  1. Simon Faissner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ralf Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Faissner.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faissner, S., Gold, R. Phase-II-Daten zeigen keine Steroideinsparung durch Rituximab. InFo Neurologie 24, 18–21 (2022). https://doi.org/10.1007/s15005-022-2352-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-022-2352-y

Search

Navigation